-
Product Insights
PB Green Solar PV Park 1
PB Green Solar PV Park 1 is a solar PV project located in Malaysia. The project is owned and being developed by Mass Team Industries Sdn Bhd; PB Green Farm Sdn Bhd. The project is at the permitting stage. Empower your strategies with our PB Green Solar PV Park 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Surufatinib in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Surufatinib in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Surufatinib in Peritoneal Cancer Drug Details: Surufatinib (Sulanda) is a potential...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bimekizumab in Ankylosing Spondylitis (Bekhterev’s Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimekizumab in Ankylosing Spondylitis (Bekhterev's Disease) Drug Details: Bimekizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PB-718 in Obesity Drug Details: PB-718 is under development for the treatment of nonalcoholic fatty...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-357 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-357 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-357 in Breast CancerDrug Details:PB-357 is under development for the treatment of breast...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-718 in Type 2 Diabetes Drug Details:PB-718 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Enfortumab Vedotin in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Enfortumab Vedotin in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enfortumab Vedotin in Transitional Cell Carcinoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PB-718 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PB-718 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:PB-718 is under development for the treatment...